Aileron Therapeutics, Inc. (ALRN) Financials
ALRN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 12.8 million | 1.6 million |
2023-06-30 | 14.0 million | 1.2 million |
2023-03-31 | 17.2 million | 2.9 million |
2022-12-31 | 22.0 million | 3.4 million |
ALRN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.6 million | 229000 |
2023-06-30 | -3.1 million | 300000 |
2023-03-31 | -4.7 million | 391000 |
2022-12-31 | -4.4 million | 424000 |
ALRN Net Income
No data available :(
ALRN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 12.1 million | - | - |
2023-06-30 | 13.7 million | - | - |
2023-03-31 | 16.7 million | - | - |
2022-12-31 | 21.2 million | - | 33000 |
ALRN Shares Outstanding
ALRN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 22000 | 2.0 million | - |
2023-06-30 | - | 187000 | 1.9 million | - |
2023-03-31 | - | 1.8 million | 2.2 million | - |
2022-12-31 | - | 2.4 million | 2.3 million | - |
ALRN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 12000 |
2023-06-30 | - | 12000 |
2023-03-31 | - | 43000 |
2022-12-31 | - | 43000 |
ALRN
Price: $3.76
52 week price:
Earnings Per Share: -2.85 USD
P/E Ratio: -1.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 28786
Ebitda: -6.4 millionMarket Capitalization: 26.1 million